the savvy bacterium listeria monocytogenes uses a one-two punch to invade the intestinal epithelium,...
TRANSCRIPT
-
8/11/2019 The savvy bacterium Listeria monocytogenes uses a one-two punch to invade the intestinal epithelium, report Mic
1/2
R E S E A R C H H I G H L I G H T S
AGING
Blame it on acetylationDuring aging, the brain gene expression pro-
gram changes, and people often suffer declines
in learning and memory. A study in mice sug-
gests that altered patterns of histone acetyla-
tion may underlie this age-related decline.
Previous studies have shown that chromatin
plasticity and histone modifications, especially
acetylation, are involved in long-term memory
and regulation of gene expression. Shahaf
Peleg et al. (Science328, 753756) exam-
ined these processes in mice as they aged
and found impaired acetylation of histone
H4 Lys12 (H4K12).
The researchers assessed the entire hip-
pocampal transcriptome of aged mice right after
subjecting them to fear conditioning training
a test for learning and memory. Compared to
younger mice, these animals failed to upregulategenes encoding proteins linked to learning and
memory formation, such as formin-2an actin
nucleator expressed in the brain. The research-
ers traced the failure to upregulate these genes
to defects in H4K12 acetylation, which specifi-
cally affected transcriptional elongation.
Treatment with a histone deacetylase
inhibitor rescued the acetylation of H4K12
in coding regions of learning-regulated genes
in aged mice. The genes were upregulated
and memory function reinstated during the
learning test. CP
REPRODUCTION
Steroids fry brain, fry testesA new study in mice might give pause to
adolescent boys contemplating using ste-
roids. Synthetic derivatives of testosterone
can alter a hormone-controlling circuit in the
brain, leading to shrunken testes, accord-
ing to a study in adolescent male mice
(J. Neurosci.30, 64976506).
Carlos Penatti et al. treated mice with
17-methyltestosterone and looked at the
response of neurons in the hypothalamusthat release gonadotropin-releasing hormone
(GnRH). GnRH prompts the production of
hormones that regulate key reproductive pro-
cesses, such as spermatogenesis.
The steroid-treated mice had reduced
action potentials in GnRH neurons, reduced
levels of reproductive hormones and reduced
testes mass. The steroid does not seem to
affect GnRH neurons directlyinstead, it
affects a nearby part of the brain, the medial
preoptic area (mPOA). Steroid administration
increased the action potential frequency of
neurons in the mPOA, which, in turn, damp-
ened the firing rate of GnRH neurons.
The findings jibe with observations that ste-
roids can delay the onset of puberty in mice
and can affect libido, testes health and sperm
production in people. CS
NEUROSCIENCE
Trimming synapsesThe neurons of individuals with fragile X syn-
drome contain an overabundance of synapses.
A study in mice suggests that a failure in syn-
aptic pruning may underlie this problem of
excess (Neuron 66, 191197).
The transcription factor myocyte enhancer
factor-2 (MEF2) drives synaptic elimination in
response to neuron firing. When Brad Pfeiffer
et al. expressed a constitutively active form of
MEF2 in hippocampal slice cultures from nor-
mal mice, they observed a decrease in spine
number and synaptic activity. These changes
were not observed when MEF2 was expressedin slice cultures from mice deficient in FMRP,
the protein behind fragile X syndrome. The
researchers found that re-expressing FMRP at
the synapses of these neurons could drive syn-
aptic elimination in response to MEF2.
FMRP and MEF2 did not seem to bind
each other to exert their effects. Instead, the
researchers suggest that these two factors may
operate in a common pathwaywith MEF2
inducing transcription in the nucleus and FMRP
binding these transcripts once they arrive at
the synapseto regulate synaptic elimination.
Future work looking at the downstream targets
of these factors could provide further insight
into fragile X syndrome. EC
IMMUNITY
Balance in the bowelOne approach to treating inflammatory bowel
disease, now in clinical trials, is to block the
activity of OX40a molecule that ramps up
the immune response by acting as a co-stim-
ulatory receptor on T cells. New findings in
mice sound a note of caution for this approach.
It seems that blocking OX40 interferes with
the function of regulatory T cells, cells that
suppress activation of the immune system
and dampen inflammation (J. Exp. Med. 207,
699709).
Colitis results from an imbalance between
effector and regulatory T cells (Treg cells) in
the gut. In mice, blocking OX40 can help rein
in effector T cells and has shown therapeutic
effects in animal models of colitis. To furtherexplore how OX40 affects the balance between
immune cells, Thibault Griseri et al.turned
to mice unable to form T and B cells (RAG-
deficient mice). They transferred colitis-induc-
ing T cells into these mice along with Treg cells.
Concurrently transferring OX40-expressing
Treg cells prevented development of disease,
whereas transfer of Tregcells deficient in OX40
resulted in severe inflammation and colitis.
Unlike OX40-expressing Treg cells, OX40-
deficient Tregcells failed to accumulate in the
colon or lymphoid organs of RAG-deficient
MICROBIOLOGY
Leaping Listeria
The savvy bacterium Listeria monocytogenesuses a
one-two punch to invade the intestinal epithelium,
report Mickey Pentecost etal.(PLoSPathog. 6,
e1000900).
At the tips of intestinal villi, extrusion ofdead cells causes the surrounding live cells to
form multicellular junctions, where normally
basolateral proteins, such as E-cadherin, are
transiently exposed to the lumen.
L. monocytogenescapitalizes on this quirk and
uses the invasin protein InlA to bind E-cadherin
and enter the cell.
In their new study, Pentecost etal.find that L. monocytogenesdeploys a second invasin,
InlB, to trigger signaling through another basolateral protein, c-Met. This signaling induces
endocytosis of E-cadherin, accelerating L. monocytogenesinvasion at the multicellular
junction. The researchers propose that other gastrointestinal pathogens may also take
advantage of this unique entry site.
In a separate study on L. monocytogenes, David Ribet et al.find that the microbe impairs
an essential post-translational modification, SUMOylation (Nature464, 11921195).
Theresearchers identified a specific bacterial protein that prompts the degradation of an enzyme
in the SUMOylation machinery, thereby weakening the host immune response.KG
L. monocytogenes(green) after invading an
intestinal villus tip (red).
P L o S P a t h o g e n s
65 0
VOLUME 16 |NUMBER 6 |JUNE 2010 NATURE MEDICINE
2010N
atureAmerica,
Inc.
Allrightsres
erved.
-
8/11/2019 The savvy bacterium Listeria monocytogenes uses a one-two punch to invade the intestinal epithelium, report Mic
2/2
R E S E A R C H H I G H L I G H T S
mice during the early stages of disease. The
researchers traced this defect to increased
apoptosis and reduced activation of OX40-
expressing Treg cells. They conclude that OX40
may act as a survival signal in Treg cells. CP
ATHEROSCLEROSIS
Insulin controls adhesionInsulin signaling in the vasculature shields
mice from atherosclerosis, according to new
research (Cell Metab. 11, 379389).
Studies on whether insulin prevents or
promotes atherosclerosis are contradictory.
To shed light on the conflict, Christian Rask-
Madsen et al.deleted the gene encoding
the insulin receptor in endothelial cells in
apolipoprotein E (apoE)-deficient mice, a model
of atherosclerosis. The double-knockout mice
had larger and more complex aortic atheroscle-
rotic lesions than did apoE-deficient mice.The researchers next examined recruit-
ment and accumulation of
inflammatory cells in the
vasculature, a key step in
the development of athero-
sclerosis. They found that
insulin seems to downregu-
late VCAM-1, a molecule on
the endothelium that binds
leukocytes. Endothelial
cells from the double-
knockout mice, for instance,
showed high expression of
VCAM-1, compared to cells
from apoE-deficient mice.
Treating wild-type endothe-
lial cells with insulin quashed
VCAM-1 protein expression.
In a system already prone to atherosclero-
sis, it seems that insulin signaling can inhibit
lesion formation by downregulating VCAM-1
expression and leukocyte adhesion. The find-
ings provide insight into how impaired insulin
signaling in the endothelium in conditions
such as type 2 diabetes should be managed to
decrease the risk of atherosclerosis. AK
Cholesterol microcontrolTwo new studies identify a noncoding RNA as a
key regulator of cholesterol homeostasis.
S. Hani Najafi-Shoushtari et al.found a
conserved microRNA, miR-33, in the intronic
sequences of two genes that encode sterol-
regulatory element-binding protein (SREBP)
transcription factors, proteins which promote
the synthesis and uptake of cholesterol and lip-
ids (Sciencedoi:10.1126/science.1189123).
Katey Rayner et al.pulled the same miRNA out
of a screen for miRNAs that respond to changes
in cholesterol levels (Sciencedoi:10.1126/
science.1189862).
Expression of miR-33 mirrored that of its
host SREBP genes in both mouse and human
cells and tissues. Among other targets, miR-33
quashes expression of ATP-binding cassette
A1 (ABCA1)a transporter protein that medi-
ates the formation of high-density lipoprotein
(HDL), the 'good' cholesterol, and aids its efflux
from cells. Overexpression of miR-33 in mice
decreased ABCA1 protein expression, whereas
inhibition of miR-33 increased ABCA1 expres-
sion and raised circulating HDL levels.
The findings suggest that manipulation of
miR-33 expression has the therapeutic poten-
tial to increase expression of ABCA1 and
thereby raise HDL levels. AK
GENOMICS
The whole thing, lots of itA clinical annotation of the complete genome
sequence of a healthy person has revealed dis-
ease risks and drug response predictions (Lancet
375, 15251535, 2010). But the work under-
scores the bioinformatic challenges remaining
before scientists can confidently apply genetic
information to personalized medicine.
Euan Ashley et al. scoured the DNA of a
40-year-old man for 2.6 million single nucle-
otide polymorphisms and more than 750 copy
number variants. Incorporating family history,
clinical measurements and known disease
associations, they showed that this individual
was at an elevated risk of developing sudden
cardiac arrest, diabetes and some cancersand
that he might benefit from cholesterol-lowering
statins.
The study emerges on the heels of two oth-
ers comparing whole-genome sequences from
people with rare genetic disorders to genetic
information from unaffected relatives. Jared
Roach et al. sequenced the DNA of a family
of four, including two adult children who suf-
fer from Miller's syndrome and primary cili-
ary dyskinesia, and pinpointed the four genes
responsible for the two diseases (Science328,636639, 2010).
James Lupski, who is afflicted with a reces-
sive form of Charcot-Marie-Tooth disease, ana-
lyzed his own genome. He and his colleagues
homed in on the mutation causing the condition
in the Baylor College of Medicine geneticist and
some of his family members (New Engl. J. Med.
362, 11811191, 2010). ED
New from NPG
Mutations of optineurin in amyotrophic
lateral sclerosis.
Maruyama, H. et al. Nature465, 223226.
A gene previously implicated in a form of
glaucoma is now pinned to amyotrophiclateral sclerosis. Mutations in the
gene affect signaling through NF-B,
suggesting that NF-B inhibitors might
be useful to treat the disease.
Human T cell epitopes of
Mycobacterium tuberculosis areevolutionarily hyperconserved.
Comas, I. et al. Nat. Genet.published online,
doi:10.1038/ng.590 (23 May).
The bits of the M. tuberculosis
bacterium recognized by the human
immune system are highly conserved
across strains. The findings suggest that
the microbe might co-opt the immune
response for its own ends and have
implications for vaccine design.
Bcl-2 and accelerated DNA repair
mediates resistance of hair follicle
bulge stem cells to DNA damage
induced cell death.
Sotiropoulou, P. A. et al. Nat. Cell Biol.published online, doi:10.1038/ncb2059
(16 May).
Stem cells in the skin are resistant to
death in response to DNA damage,
and they repair DNA relatively quickly.
This speed is due to high activity of
nonhomologous end joining, a repair
mechanism that is prone to errors. It
seems that these stem cells are primed
to survive despite damage and tend to
accumulate mutationsa finding with
implications for tumorigenesis and aging.
Chemical genetics strategy identifies
an HCV NS5A inhibitor with a potent
clinical effect.
Gao, M. et al.Nature 465, 96100.
In phase 1 clinical trials, a new drug
substantially reduced the viral load of
chronically infected subjects.
Written by Eva Chmielnicki, Elie Dolgin,
Katherine Gora, Anna Kushnir, Carolina Pola and
Charlotte Schubert
Plaques in
the double
knockout mice.
NLRP3 inflammasomes are required
for atherogenesis and activated by
cholesterol crystals.
Duewell, P. et al.Nature464, 13571361.
The findings provide insight into the long-
standing question of whether cholesterol
is an early trigger of atherosclerosis
or a consequence of the condition.
Cholesterol crystals can activate a protein
complex dubbed the inflammasome,
resulting in inflammation that promotes
atherosclerosis.
CellPress
NATURE MEDICINE
VOLUME 16 |NUMBER 6 |JUNE 2010
65 1
2010N
atureAmerica,
Inc.
Allrightsres
erved.